Literature DB >> 21333013

Primary extraskeletal osteosarcoma of omentum majus.

Shui-Xiang Tao1, Guo-Qin Tian, Meng-Hua Ge, Cheng-Long Fan.   

Abstract

Extraskeletal osteosarcoma is a rare malignant soft tissue tumor. Here we present a case of a primary extraskeletal osteosarcoma arising from omentum majus in a 40-year-old Chinese woman. Ultrasonography of the pelvic cavity showed a large soft tissue mass with marked calcification. Complete surgical resection of the primary tumor was performed and the histopathological diagnosis was extraskeletal osteosarcoma of omentum majus. She was followed up without adjuvant radiotherapy and chemotherapy, and died from widespread intra-abdominal, lung and liver metastases 7 months postoperatively.

Entities:  

Mesh:

Year:  2011        PMID: 21333013      PMCID: PMC3046909          DOI: 10.1186/1477-7819-9-25

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  11 in total

1.  Retroperitoneal extraskeletal osteosarcoma.

Authors:  C S van Rijswijk; J G Lieng; H M Kroon; P C Hogendoorn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Combined replacement of infrarenal aorta and inferior vena cava after en bloc resection of retroperitoneal extraosseous osteosarcoma.

Authors:  Joseph R Schneider; Stephen F Sener; Ermilo Barrera
Journal:  J Vasc Surg       Date:  2008-08       Impact factor: 4.268

3.  Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases.

Authors:  M Lidang Jensen; B Schumacher; O Myhre Jensen; O Steen Nielsen; J Keller
Journal:  Am J Surg Pathol       Date:  1998-05       Impact factor: 6.394

4.  Osteogenic sarcoma of the somatic soft tissues. Clinicopathologic study of 26 cases and review of literature.

Authors:  C J Allan; E H Soule
Journal:  Cancer       Date:  1971-05       Impact factor: 6.860

5.  Primary osteosarcoma of the greater omentum.

Authors:  R Salm
Journal:  J Pathol Bacteriol       Date:  1965-10

6.  Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases.

Authors:  B L Bane; H L Evans; J Y Ro; C H Carrasco; D J Grignon; R S Benjamin; A G Ayala
Journal:  Cancer       Date:  1990-06-15       Impact factor: 6.860

7.  Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma.

Authors:  Sing Yu Goldstein-Jackson; Georg Gosheger; Günter Delling; Wolfgang E Berdel; G Ulrich Exner; Gernot Jundt; Jan-Nicolas Machatschek; Andreas Zoubek; Heribert Jürgens; Stefan S Bielack
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-26       Impact factor: 4.553

8.  Extraskeletal osteosarcoma.

Authors:  E B Chung; F M Enzinger
Journal:  Cancer       Date:  1987-09-01       Impact factor: 6.860

9.  From the archives of the AFIP. Extraskeletal osseous and cartilaginous tumors of the extremities.

Authors:  M J Kransdorf; J M Meis
Journal:  Radiographics       Date:  1993-07       Impact factor: 5.333

10.  Small cell extraskeletal osteosarcoma.

Authors:  Jun Young Yang; Jin Man Kim
Journal:  Orthopedics       Date:  2009-03       Impact factor: 1.390

View more
  4 in total

1.  Large retroperitoneal low-grade extraskeletal osteosarcoma.

Authors:  Jiten Jaipuria; Ashok Kumar; Adla Satyanarayan Rao; Satya Pal Kataria
Journal:  BMJ Case Rep       Date:  2014-03-22

2.  A Primary Extraskeletal Osteosarcoma of the Spleen: Rare Case Report.

Authors:  Xian Pan; Han-Lu Wang; Shi-Ming Lin; Jia-Li Lin; Dan-Dan Ruan; Jian-Hui Zhang; Ting Chen; Jie-Wei Luo; Zhu-Ting Fang
Journal:  Front Oncol       Date:  2022-05-02       Impact factor: 5.738

3.  Gastric wall implantation metastasis of retroperitoneal extraskeletal osteosarcoma: A case report and review of the literature.

Authors:  Yan Liu; Bin Hu; Jing-Xia Li; Lu-Qi Xing; Bao-Ping Liu
Journal:  Oncol Lett       Date:  2014-10-10       Impact factor: 2.967

Review 4.  Primary orbital extraskeletal osteosarcoma and review of literature.

Authors:  Jingwen Hui; Yun Zhao; Lei Zhang; Jinyong Lin; Hong Zhao
Journal:  BMC Ophthalmol       Date:  2020-10-22       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.